Ignite Creation Date:
2024-05-06 @ 2:03 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04200963
Status:
COMPLETED
Last Update Posted:
2024-03-15
First Post:
2019-12-11
Brief Title:
A Phase 1ab Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
Sponsor:
Ikena Oncology
Organization:
Ikena Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-18
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-11
First Submit QC Date:
December 13 2019
Study First Post Date:
2019-12-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-14
Last Update Post Date:
2024-03-15
Last Update Post Date Type:
ACTUAL